Jodi Olson has reportedly left Alphabet’s early-stage investment arm, where she had been a communications and marketing partner for roughly a decade.

The oncology analytics software developer received a top-up from investors including NEC Corporation at a unicorn valuation.

Pfizer Ventures was among the investors in Triana’s series A round and has taken a board seat at the molecular glue platform developer.

The Takeda spinoff is developing a vaccine for acute gastroenteritis caused by norovirus infection, and raised about $140m in August 2021.

Wipro and Intel backed customer experience platform developer Lilt's $55m series C while Pfizer is buying corporate-backed respiratory virus therapeutic developer ReViral for up to $525m.

China Life Private Equity Investment and PICC Capital returned to co-lead the pharmaceutical discovery technology provider’s latest rounds, four months after it emerged from stealth.

Mitsui took part in oncology therapy developer Ensem Therapeutics' $67m series A round while Bioventus is paying up to $450m to buy the rest of portfolio company CartiHeal.

The drug retailer’s AB Health Ventures unit will focus on early to mid-stage healthcare technology providers working on areas including pharmaceutical distribution, commercialisation and pet care.

SoftBank Vision Fund 2 led the healthcare management software provider’s series D round, taking its overall funding to about $213m and its valuation to a reported $1.4bn.

Kaiser Permanente Ventures returned to reinvest in the nursing staff management service at a $1.1bn valuation.